Meilleure Health International Industry Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
44.00
57.00
40.00
96.00
107.00
16.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
188.00
-166.00
16.00
-123.00
1.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
188.00
-117.00
38.00
-78.00
95.00
14.00
Cash Flow from Investing Activities
-271.00
35.00
-141.00
148.00
68.00
-359.00
Cash Flow from Financing Activities
3.00
-7.00
53.00
-29.00
-176.00
412.00
Net Cash Inflow / Outflow
-80.00
-92.00
-61.00
39.00
-5.00
68.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
-3.00
-11.00
0.00
7.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Meilleure Health International Industry Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
44.592
504.3364783555
-460.00
-91.16%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
188.996
154.96702958531
34.00
21.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
188.748
764.061215603584
-576.00
-75.30%
Cash Flow from Investing Activities
-271.586
-475.947161263365
204.00
42.94%
Cash Flow from Financing Activities
3.872
-411.233092775805
414.00
100.94%
Net Cash Inflow / Outflow
-80.96
-119.77854477683
39.00
32.41%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.994
3.34049365875603
-4.00
-159.69%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 260.14% vs -405.01% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
188.75
-117.86
260.14%






